Application 020646
- Type
- NDA
- Sponsor
- CEPHALON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 4MG | Yes | Yes |
| 002 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 12MG | Yes | No |
| 003 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 16MG | Yes | No |
| 004 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 20MG | No | No |
| 005 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 2MG | Yes | No |
| 006 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 6MG | No | No |
| 007 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 8MG | No | No |
| 008 | GABITRIL | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020646-001 | GABITRIL | TIAGABINE HYDROCHLORIDE | 4MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 |
| N020646-002 | GABITRIL | TIAGABINE HYDROCHLORIDE | 12MG | TABLET / ORAL | AB | RLD | 1997-09-30 |
| N020646-003 | GABITRIL | TIAGABINE HYDROCHLORIDE | 16MG | TABLET / ORAL | AB | RLD | 1997-09-30 |
| N020646-004 | GABITRIL | TIAGABINE HYDROCHLORIDE | 20MG | TABLET / ORAL | 1997-09-30 | ||
| N020646-005 | GABITRIL | TIAGABINE HYDROCHLORIDE | 2MG | TABLET / ORAL | AB | RLD | 1999-04-16 |
| N020646-006 | GABITRIL | TIAGABINE HYDROCHLORIDE | 6MG | TABLET / ORAL | 2005-11-29 | ||
| N020646-007 | GABITRIL | TIAGABINE HYDROCHLORIDE | 8MG | TABLET / ORAL | 2005-11-29 | ||
| N020646-008 | GABITRIL | TIAGABINE HYDROCHLORIDE | 10MG | TABLET / ORAL | 2005-11-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020646-001 | AB |
| N020646-002 | AB |
| N020646-003 | AB |
| N020646-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020646-001 | GABITRIL | 4MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020646-002 | GABITRIL | 12MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020646-003 | GABITRIL | 16MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020646-004 | GABITRIL | 20MG | TABLET / ORAL | 1997-09-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020646-005 | GABITRIL | 2MG | TABLET / ORAL | AB | RLD | 1999-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020646-006 | GABITRIL | 6MG | TABLET / ORAL | 2005-11-29 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020646-007 | GABITRIL | 8MG | TABLET / ORAL | 2005-11-29 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020646-008 | GABITRIL | 10MG | TABLET / ORAL | 2005-11-29 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-001 | GABITRIL | 4MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-002 | GABITRIL | 12MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-003 | GABITRIL | 16MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-004 | GABITRIL | 20MG | TABLET / ORAL | 1997-09-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-005 | GABITRIL | 2MG | TABLET / ORAL | AB | RLD | 1999-04-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-006 | GABITRIL | 6MG | TABLET / ORAL | 2005-11-29 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-007 | GABITRIL | 8MG | TABLET / ORAL | 2005-11-29 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-008 | GABITRIL | 10MG | TABLET / ORAL | 2005-11-29 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020646-001 | GABITRIL | 4MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-002 | GABITRIL | 12MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-003 | GABITRIL | 16MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-004 | GABITRIL | 20MG | TABLET / ORAL | 1997-09-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020646-005 | GABITRIL | 2MG | TABLET / ORAL | AB | RLD | 1999-04-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-006 | GABITRIL | 6MG | TABLET / ORAL | 2005-11-29 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020646-007 | GABITRIL | 8MG | TABLET / ORAL | 2005-11-29 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020646-008 | GABITRIL | 10MG | TABLET / ORAL | 2005-11-29 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-001 | GABITRIL | 4MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-002 | GABITRIL | 12MG | TABLET / ORAL | AB | RLD | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-003 | GABITRIL | 16MG | TABLET / ORAL | AB | RLD | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-004 | GABITRIL | 20MG | TABLET / ORAL | 1997-09-30 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-005 | GABITRIL | 2MG | TABLET / ORAL | AB | RLD | 1999-04-16 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-006 | GABITRIL | 6MG | TABLET / ORAL | 2005-11-29 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-007 | GABITRIL | 8MG | TABLET / ORAL | 2005-11-29 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-008 | GABITRIL | 10MG | TABLET / ORAL | 2005-11-29 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-001 | GABITRIL | 4MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-002 | GABITRIL | 12MG | TABLET / ORAL | AB | RLD | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-003 | GABITRIL | 16MG | TABLET / ORAL | AB | RLD | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-004 | GABITRIL | 20MG | TABLET / ORAL | 1997-09-30 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-005 | GABITRIL | 2MG | TABLET / ORAL | AB | RLD | 1999-04-16 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-006 | GABITRIL | 6MG | TABLET / ORAL | 2005-11-29 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-007 | GABITRIL | 8MG | TABLET / ORAL | 2005-11-29 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-008 | GABITRIL | 10MG | TABLET / ORAL | 2005-11-29 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020646-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020646-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020646-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020646-005 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020646-005 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020646-005 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020646-005 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020646-005 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020646-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020646-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020646-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020646-005 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020646-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020646-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020646-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020646-005 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020646-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020646-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020646-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020646-005 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020646-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020646-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020646-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020646-005 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020646-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020646-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020646-003 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020646-005 | AB | 1 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tiagabine Hydrochloride | TIAGABINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 953ef3cc-e3cb-480f-b9ea-256520fd62b8 | 2021-09-30 | Warnings, Adverse reactions | 020646 NDA020646 0093-8072 0093-5031 0093-8076 0093-5030 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, LLC | NDA | Current |
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, LLC | NDA | Current |
| 63459-404 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, LLC | NDA | Current |
| 63459-412 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, LLC | NDA | Current |
| 63459-416 | GABITRIL | Tiagabine Hydrochloride | Cephalon, Inc. | NDA | Current |
| 68151-4235 | GABITRIL | Tiagabine Hydrochloride | Carilion Materials Management | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82035 | SUPPL | 2025-04-28 |
| 74755 | SUPPL | 2023-07-13 |
| 73680 | SUPPL | 2023-03-06 |
| 45034 | SUPPL | 2016-08-09 |
| 45020 | SUPPL | 2016-08-09 |
| 12920 | SUPPL | 2015-11-12 |
| 25436 | SUPPL | 2015-11-09 |
| 25437 | SUPPL | 2012-01-30 |
| 43662 | ORIG | 2010-10-13 |
| 25435 | SUPPL | 2010-10-13 |
| 35073 | SUPPL | 2010-10-11 |
| 41520 | ORIG | 2010-01-07 |
| 35072 | SUPPL | 2009-05-12 |
| 2996 | SUPPL | 2009-05-04 |
| 2995 | SUPPL | 2005-12-06 |
| 35071 | SUPPL | 2005-12-05 |
| 44063 | ORIG | 2005-04-15 |
| 35070 | SUPPL | 2005-02-17 |
| 2994 | SUPPL | 2005-02-17 |